BRIEF-Loblaw sees $1.3 billion in 2016 capital expenditures

Wed Jul 27, 2016 7:36am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article | Single Page
[-] Text [+]

July 27 (Reuters) - Loblaw Companies Ltd

* Qtrly adjusted diluted net earnings per common share were $1.01

* Qtrly drug retail (shoppers drug mart) same-store sales growth was 4.0%

* Q2 retail segment sales were $10,494 million, an increase of $176 million, or 1.7%, compared to q2 of 2015

* To return capital to shareholders by allocating a significant portion of free cash flow to share repurchases in 2016

* Sees for 2016 approximately $1.3 billion in capital expenditures

* Q2 earnings per share view c$0.94, revenue view c$10.75 billion -- Thomson Reuters I/B/E/S

* Fy2016 earnings per share view c$3.86, revenue view c$46.57 billion -- Thomson Reuters I/B/E/S

* Says   Continued...